243 related articles for article (PubMed ID: 29761078)
1. Novel Immunotherapy Options for Extranodal NK/T-Cell Lymphoma.
Hu B; Oki Y
Front Oncol; 2018; 8():139. PubMed ID: 29761078
[TBL] [Abstract][Full Text] [Related]
2. Selection of new immunotherapy targets for NK/T cell lymphoma.
Lv K; Li X; Yu H; Chen X; Zhang M; Wu X
Am J Transl Res; 2020; 12(11):7034-7047. PubMed ID: 33312349
[TBL] [Abstract][Full Text] [Related]
3. Updating targets for natural killer/T-cell lymphoma immunotherapy.
Xue W; Zhang M
Cancer Biol Med; 2021 Feb; 18(1):52-62. PubMed ID: 33628584
[TBL] [Abstract][Full Text] [Related]
4. The landscape of new drugs in extranodal NK/T-cell lymphoma.
Wang L; Li LR; Zhang L; Wang JW
Cancer Treat Rev; 2020 Sep; 89():102065. PubMed ID: 32653806
[TBL] [Abstract][Full Text] [Related]
5. PD-L1 is upregulated by EBV-driven LMP1 through NF-κB pathway and correlates with poor prognosis in natural killer/T-cell lymphoma.
Bi XW; Wang H; Zhang WW; Wang JH; Liu WJ; Xia ZJ; Huang HQ; Jiang WQ; Zhang YJ; Wang L
J Hematol Oncol; 2016 Oct; 9(1):109. PubMed ID: 27737703
[TBL] [Abstract][Full Text] [Related]
6. Long-term Outcome of Extranodal NK/T Cell Lymphoma Patients Treated With Postremission Therapy Using EBV LMP1 and LMP2a-specific CTLs.
Cho SG; Kim N; Sohn HJ; Lee SK; Oh ST; Lee HJ; Cho HI; Yim HW; Jung SE; Park G; Oh JH; Choi BO; Kim SW; Kim SW; Chung NG; Lee JW; Hong YS; Kim TG
Mol Ther; 2015 Aug; 23(8):1401-1409. PubMed ID: 26017177
[TBL] [Abstract][Full Text] [Related]
7. Extranodal NK-/T-cell lymphoma, nasal type: what advances have been made in the last decade?
Costa RO; Pereira J; Lage LAPC; Baiocchi OCG
Front Oncol; 2023; 13():1175545. PubMed ID: 37529691
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in the diagnosis and treatment of natural killer/T-cell lymphomas.
Tse E; Au-Yeung R; Kwong YL
Expert Rev Hematol; 2019 Nov; 12(11):927-935. PubMed ID: 31487202
[No Abstract] [Full Text] [Related]
9. Diagnosis and management of extranodal NK/T cell lymphoma nasal type.
Tse E; Kwong YL
Expert Rev Hematol; 2016 Sep; 9(9):861-71. PubMed ID: 27347812
[TBL] [Abstract][Full Text] [Related]
10. [Advances in immunotherapy of extranodal NK/T cell lymphoma].
Hao DQ; Li LQ; Li MC; Gong LL
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Dec; 54(12):949-953. PubMed ID: 31887826
[TBL] [Abstract][Full Text] [Related]
11. Treatment of extranodal NK/T-cell lymphoma: From past to future.
Yan Z; Yao S; Wang Z; Zhou W; Yao Z; Liu Y
Front Immunol; 2023; 14():1088685. PubMed ID: 36825002
[TBL] [Abstract][Full Text] [Related]
12. EBV and the Pathogenesis of NK/T Cell Lymphoma.
Montes-Mojarro IA; Fend F; Quintanilla-Martinez L
Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33808787
[TBL] [Abstract][Full Text] [Related]
13. Clinical Efficacy of Programmed Cell Death Ligand 1 Antibody in Treatment of Extranodal Natural Killer/T-Cell Lymphoma With Hemophagocytic Lymphohistiocytosis.
Yang CL; Chen X; Zhou HJ; Wu WC; Zou LQ
J Hematol; 2024 Apr; 13(1-2):46-51. PubMed ID: 38644986
[TBL] [Abstract][Full Text] [Related]
14. Serum EBV EA-IgA and VCA-IgA antibodies can be used for risk group stratification and prognostic prediction in extranodal NK/T cell lymphoma: 24-year experience at a single institution.
Huang Y; Rao H; Yan S; Wang F; Wu Q; Feng Y; Zhang Y
Ann Hematol; 2017 Aug; 96(8):1331-1342. PubMed ID: 28550598
[TBL] [Abstract][Full Text] [Related]
15. Advances and challenges of immunotherapies in NK/T cell lymphomas.
He L; Chen N; Dai L; Peng X
iScience; 2023 Nov; 26(11):108192. PubMed ID: 38026157
[TBL] [Abstract][Full Text] [Related]
16. NK/T-cell lymphomas.
Tse E; Kwong YL
Best Pract Res Clin Haematol; 2019 Sep; 32(3):253-261. PubMed ID: 31585625
[TBL] [Abstract][Full Text] [Related]
17. Rare case of low-grade extranodal NK/T-cell lymphoma, nasal type, arising in the setting of chronic rhinosinusitis and harboring a novel N-terminal KIT mutation.
Devins K; Schuster SJ; Caponetti GC; Bogusz AM
Diagn Pathol; 2018 Nov; 13(1):92. PubMed ID: 30470245
[TBL] [Abstract][Full Text] [Related]
18. [Advances of treatment for extranodal NK/T-cell lymphoma --- review].
Zhang SS; Wei M; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Aug; 19(4):1075-8. PubMed ID: 21867647
[TBL] [Abstract][Full Text] [Related]
19. NK/T Cell Lymphoma: Updates in Therapy.
Suzuki R
Curr Hematol Malig Rep; 2018 Feb; 13(1):7-12. PubMed ID: 29368155
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of L-asparaginase-based regimens compared to anthracycline-based regimens in newly diagnosed extranodal NK/T-cell lymphoma, nasal type: a single Mexican center experience.
Ávila Milord AA; Aguilar Hernández MM; Demichelis Gómez R; Agreda Vásquez GP
Blood Res; 2018 Sep; 53(3):210-217. PubMed ID: 30310787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]